Chromatin Regulatory Targets for Anticancer Therapeutics

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• Chromatin organizes the genome and regulates gene expression critical for cell differentiation.
• Early anti-cancer agents targeting chromatin regulatory enzymes spurred interest in this drug development area.
• Advances in chemistry and target selection have fueled chromatin-based drug discovery.

Purpose of the Study:

• To reflect on the successes and failures of translating chromatin regulatory targets into anti-cancer drugs.
• To evaluate the efficacy of specific chromatin regulatory targets and the drugs developed against them.
• To assess future prospects for chromatin-targeted cancer therapies.

Main Methods:

• Target-centric review of chromatin regulatory proteins as anti-cancer drug targets.
• Analysis of chemical strategies enabling small molecule discovery and development against chromatin targets.
• Evaluation of clinical successes and failures in chromatin-targeted drug development.

Main Results:

• A rich collection of chemical probes, drugs, and drug candidates targeting chromatin regulatory processes has been produced.
• Significant progress has been made in understanding the druggability of chromatin regulatory targets.
• The field has matured, providing valuable insights into the challenges and opportunities in this therapeutic area.

Conclusions:

• Chromatin regulatory targets represent a promising avenue for anti-cancer drug development.
• Continued innovation in chemistry and target validation is crucial for future success.
• A critical evaluation of past efforts is essential for optimizing future drug discovery strategies in this field.